Search

Your search keyword '"Fuchs, Michael"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Fuchs, Michael" Remove constraint Author: "Fuchs, Michael" Journal journal of hepatology Remove constraint Journal: journal of hepatology
31 results on '"Fuchs, Michael"'

Search Results

1. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

2. A global research priority agenda to advance public health responses to fatty liver disease

4. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

5. Stigma in NAFLD and NASH: a global survey of patients and providers

6. Substitution of even one non-vegetarian meal with plant-based alternatives associate with lower ammoniagenesis in patients with cirrhosis who follow a western diet: a randomized clinical trial

9. GS-001 Thematic trial: phase 2 dose-ranging randomized clinical trial of capsular or enema fecal microbiota transplant to prevent hepatic encephalopathy in cirrhosis already on Rifaximin and Lactulose

10. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy

11. THU-453 - Stigma in NAFLD and NASH: a global survey of patients and providers

15. Gut microbiota are associated with minimal hepatic encephalopathy (MHE) in cirrhosis regardless of country of origin

16. Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the U.S. is cost effective: A comprehensive economical analysis

17. Fecal microbial transplant reduces short-term cravings, improves quality of life and microbial diversity in cirrhosis and alcohol use disorder: a randomized, placebo-controlled, clinical trial

18. Salivary and stool microbiota differences are related to differences in 90-day hospitalizations in Mexican compared to American patients with cirrhosis

21. PS-087-Fecal microbiota capsules are safe and effective in patients with recurrent hepatic encephalopathy: A randomized, blinded, placebo-controlled trial

22. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis

23. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

24. Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis

27. THU194 - Gut microbiota are associated with minimal hepatic encephalopathy (MHE) in cirrhosis regardless of country of origin.

29. LBP22 - Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the U.S. is cost effective: A comprehensive economical analysis.

30. AS081 - Fecal microbial transplant reduces short-term cravings, improves quality of life and microbial diversity in cirrhosis and alcohol use disorder: a randomized, placebo-controlled, clinical trial.

Catalog

Books, media, physical & digital resources